| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.1987.5.7.1022 |
| P698 | PubMed publication ID | 2439659 |
| P2093 | author name string | A T Look | |
| R Harris | |||
| T J Vietti | |||
| J Krischer | |||
| N Hakami | |||
| Y Ravindranath | |||
| R Castleberry | |||
| P C Steuber | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | etoposide | Q418817 |
| P304 | page(s) | 1022-1025 | |
| P577 | publication date | 1987-07-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study | |
| P478 | volume | 5 |
| Q39522965 | Biologic characteristics and treatment of acute nonlymphocytic leukemia in children. Report of the ANLL Strategy Group of the Childrens Cancer Study Group |
| Q36338036 | Inhibitors of DNA methylation: beyond myelodysplastic syndromes |
| Q54297763 | Toxicity trials of amsacrine (AMSA) and etoposide +/? azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study |
| Q41055118 | Treatment of childhood acute myeloid leukaemia |
| Q37909059 | Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment |